vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and Where Food Comes From, Inc. (WFCF). Click either name above to swap in a different company.

Baird Medical Investment Holdings Ltd is the larger business by last-quarter revenue ($8.0M vs $6.0M, roughly 1.3× Where Food Comes From, Inc.). Where Food Comes From, Inc. runs the higher net margin — -3.4% vs -142.7%, a 139.4% gap on every dollar of revenue. Where Food Comes From, Inc. produced more free cash flow last quarter ($-741.0K vs $-3.2M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

Where Food Comes From, Inc. is a leading provider of food traceability, verification, and certification solutions for the agricultural and food production industries. Its services support producers, processors, and retailers across North America to validate food origin, sustainability practices, animal welfare standards, and product authenticity for end consumers.

BDMD vs WFCF — Head-to-Head

Bigger by revenue
BDMD
BDMD
1.3× larger
BDMD
$8.0M
$6.0M
WFCF
Higher net margin
WFCF
WFCF
139.4% more per $
WFCF
-3.4%
-142.7%
BDMD
More free cash flow
WFCF
WFCF
$2.5M more FCF
WFCF
$-741.0K
$-3.2M
BDMD

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BDMD
BDMD
WFCF
WFCF
Revenue
$8.0M
$6.0M
Net Profit
$-11.4M
$-203.0K
Gross Margin
82.1%
35.9%
Operating Margin
-131.3%
-1.0%
Net Margin
-142.7%
-3.4%
Revenue YoY
-9.3%
Net Profit YoY
-121.1%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
WFCF
WFCF
Q4 25
$6.0M
Q3 25
$7.0M
Q2 25
$8.0M
$6.6M
Q1 25
$5.3M
Q4 24
$6.7M
Q3 24
$7.1M
Q2 24
$6.4M
Q1 24
$5.6M
Net Profit
BDMD
BDMD
WFCF
WFCF
Q4 25
$-203.0K
Q3 25
$1.1M
Q2 25
$-11.4M
$562.0K
Q1 25
$31.0K
Q4 24
$961.0K
Q3 24
$492.0K
Q2 24
$489.0K
Q1 24
$178.0K
Gross Margin
BDMD
BDMD
WFCF
WFCF
Q4 25
35.9%
Q3 25
38.3%
Q2 25
82.1%
37.5%
Q1 25
41.6%
Q4 24
42.0%
Q3 24
39.0%
Q2 24
41.6%
Q1 24
41.7%
Operating Margin
BDMD
BDMD
WFCF
WFCF
Q4 25
-1.0%
Q3 25
8.2%
Q2 25
-131.3%
8.4%
Q1 25
2.7%
Q4 24
11.3%
Q3 24
8.6%
Q2 24
9.1%
Q1 24
4.7%
Net Margin
BDMD
BDMD
WFCF
WFCF
Q4 25
-3.4%
Q3 25
16.3%
Q2 25
-142.7%
8.6%
Q1 25
0.6%
Q4 24
14.4%
Q3 24
6.9%
Q2 24
7.6%
Q1 24
3.2%
EPS (diluted)
BDMD
BDMD
WFCF
WFCF
Q4 25
$-0.04
Q3 25
$0.22
Q2 25
$0.11
Q1 25
$0.01
Q4 24
$0.19
Q3 24
$0.09
Q2 24
$0.09
Q1 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
WFCF
WFCF
Cash + ST InvestmentsLiquidity on hand
$3.2M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$35.6M
$9.3M
Total Assets
$77.0M
$12.9M
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
WFCF
WFCF
Q4 25
$3.2M
Q3 25
$4.8M
Q2 25
$3.2M
Q1 25
$2.2M
Q4 24
$2.0M
Q3 24
$2.8M
Q2 24
$2.6M
Q1 24
$1.9M
Total Debt
BDMD
BDMD
WFCF
WFCF
Q4 25
Q3 25
Q2 25
$8.4M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BDMD
BDMD
WFCF
WFCF
Q4 25
$9.3M
Q3 25
$10.3M
Q2 25
$35.6M
$10.0M
Q1 25
$9.6M
Q4 24
$9.9M
Q3 24
$9.5M
Q2 24
$9.7M
Q1 24
$9.6M
Total Assets
BDMD
BDMD
WFCF
WFCF
Q4 25
$12.9M
Q3 25
$16.9M
Q2 25
$77.0M
$16.6M
Q1 25
$15.2M
Q4 24
$15.3M
Q3 24
$16.9M
Q2 24
$16.8M
Q1 24
$15.4M
Debt / Equity
BDMD
BDMD
WFCF
WFCF
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
WFCF
WFCF
Operating Cash FlowLast quarter
$-3.2M
$-707.0K
Free Cash FlowOCF − Capex
$-3.2M
$-741.0K
FCF MarginFCF / Revenue
-40.7%
-12.3%
Capex IntensityCapex / Revenue
0.6%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
WFCF
WFCF
Q4 25
$-707.0K
Q3 25
$501.0K
Q2 25
$-3.2M
$1.2M
Q1 25
$632.0K
Q4 24
$-50.0K
Q3 24
$912.0K
Q2 24
$1.2M
Q1 24
$700.0K
Free Cash Flow
BDMD
BDMD
WFCF
WFCF
Q4 25
$-741.0K
Q3 25
$443.0K
Q2 25
$-3.2M
$1.1M
Q1 25
$603.0K
Q4 24
$-79.0K
Q3 24
$873.0K
Q2 24
$1.1M
Q1 24
$676.0K
FCF Margin
BDMD
BDMD
WFCF
WFCF
Q4 25
-12.3%
Q3 25
6.3%
Q2 25
-40.7%
17.5%
Q1 25
11.4%
Q4 24
-1.2%
Q3 24
12.3%
Q2 24
17.2%
Q1 24
12.1%
Capex Intensity
BDMD
BDMD
WFCF
WFCF
Q4 25
0.6%
Q3 25
0.8%
Q2 25
0.6%
0.5%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
1.0%
Q1 24
0.4%
Cash Conversion
BDMD
BDMD
WFCF
WFCF
Q4 25
Q3 25
0.44×
Q2 25
2.10×
Q1 25
20.39×
Q4 24
-0.05×
Q3 24
1.85×
Q2 24
2.39×
Q1 24
3.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDMD
BDMD

Segment breakdown not available.

WFCF
WFCF

Verification And Certification Service Revenue$5.0M83%
Other$1.0M17%

Related Comparisons